Format

Send to

Choose Destination
Eur J Clin Microbiol Infect Dis. 2017 Dec;36(12):2303-2317. doi: 10.1007/s10096-017-3060-2. Epub 2017 Aug 7.

Close association between intestinal microbiota and irritable bowel syndrome.

Fan WT1, Ding C2,3, Xu NN1, Zong S4, Ma P5,6,7, Gu B8,9,10.

Author information

1
Medical Technology Institute of Xuzhou Medical University, Xuzhou, 221004, China.
2
Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
3
Department of General Surgery, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China.
4
Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China.
5
Medical Technology Institute of Xuzhou Medical University, Xuzhou, 221004, China. pingm62@aliyun.com.
6
Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China. pingm62@aliyun.com.
7
Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, No. 99 West Huaihai Road, Xuzhou, 221006, China. pingm62@aliyun.com.
8
Medical Technology Institute of Xuzhou Medical University, Xuzhou, 221004, China. gb20031129@163.com.
9
Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, China. gb20031129@163.com.
10
Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, No. 99 West Huaihai Road, Xuzhou, 221006, China. gb20031129@163.com.

Abstract

Trillions of microbes inhabiting the intestine form a complex ecological community, affecting the normal physiology and pathological susceptibility through their collective metabolic activities and interactions with the host. Increased numbers of diseases have been found to be associated with disturbances in this ecosystem. There is evidence that intestinal microflora undergoes alterations in patients with irritable bowel syndrome (IBS). IBS is a frequent functional gut disease with negative impact on the patient's quality of life. Although the etiology and pathology of IBS remain largely unknown, it is generally accepted that the interaction between the microbiota and the host is associated with IBS. However, there are no specific or effective therapies for the treatment of IBS at present. In recent years, researchers have shown a growing interest in seeking safer and more effective alternatives for the treatment of IBS by focusing their attention on the potential role of probiotics and prebiotics. In this review, we will discuss alterations in intestinal microbiota and how these alterations may exacerbate IBS, and introduce several new IBS treatment options aiming at re-establishing a healthy and beneficial ecosystem.

PMID:
28785822
DOI:
10.1007/s10096-017-3060-2
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center